Seelos Therapeutics to Participate in the Guggenheim Nantucket Therapeutics Conference

NEW YORK, Sept. 9, 2022 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the develo...

Related Keywords

New York ,United States ,Yatin Suneja ,Raj Mehra ,Mike Moyer ,Anthony Marciano ,Prnewswire Seelos Therapeutics Inc ,Lifesci Advisors ,Seelos Therapeutics Inc ,Nasdaq ,Guggenheim Nantucket Therapeutics Conference ,Senior Biotechnology Analyst Yatin Suneja ,Acute Suicidal Ideation ,Major Depressive Disorder ,Sci Advisors ,